Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (131-140 of 252) with videos related to

Pageof 26
Sort By:
Gastroenterologie Clinique Et Biologique|March 31, 2007
[Cytomegalovirus and cryptogenic inflammatory bowel disease]Joanna Pofelski, Frédéric Heluwaert, Xavier Roblin, et al.
Microorganisms|July 24, 2020
Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)Alexandre Jentzer, Pauline Veyrard, Xavier Roblin, et al.
Journal of Clinical Medicine|May 28, 2019
Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis PatientsMélanie Rinaudo-Gaujous, Vincent Blasco-Baque, Pierre Miossec, et al.
Inflammatory Bowel Diseases|January 11, 2012
Prevalence of cytomegalovirus infection in steroid-refractory Crohn's diseaseXavier Roblin, Sylvie Pillet, Philippe Berthelot, et al.
Journal of Crohn'S & Colitis|November 7, 2023
Higher Serum Infliximab Concentrations Following Subcutaneous Dosing are Associated with Deep Remission in Patients with Inflammatory Bowel DiseaseXavier Roblin, Stéphane Nancey, Konstantinos Papamichael, et al.
World Journal of Clinical Oncology|March 2, 2017
Difficult endoscopic diagnosis of a pancreatic plasmacytoma: Case report and review of literatureNicolas Williet, Radwan Kassir, Muriel Cuilleron, et al.
Pancreas|May 3, 2021
A Low Total Psoas Muscle Area Index Is a Strong Prognostic Factor in Metastatic Pancreatic CancerNicolas Williet, Marion Fovet, Khawla Maoui, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 26, 2019
Trough Levels of Infliximab at Week 6 Are Predictive of Remission at Week 14 in Pediatric Crohn's DiseaseOlivier Courbette, Camille Aupiais, Jérôme Viala, et al.
Inflammatory Bowel Diseases|May 17, 2014
Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysisStephane Paul, Amelie Carla Moreau, Emilie Del Tedesco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 17, 2017
Azathioprine for refractory ulcerative proctitis: A retrospective multicenter studyAnne-Laure Mallet, Guillaume Bouguen, Guillaume Conroy, et al.
Pageof 26

Showing results (131-140 of 252) with videos related to

Sort By:
Pageof 26
Gastroenterologie Clinique Et Biologique|March 31, 2007
[Cytomegalovirus and cryptogenic inflammatory bowel disease]Joanna Pofelski, Frédéric Heluwaert, Xavier Roblin, et al.
Microorganisms|July 24, 2020
Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)Alexandre Jentzer, Pauline Veyrard, Xavier Roblin, et al.
Journal of Clinical Medicine|May 28, 2019
Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis PatientsMélanie Rinaudo-Gaujous, Vincent Blasco-Baque, Pierre Miossec, et al.
Inflammatory Bowel Diseases|January 11, 2012
Prevalence of cytomegalovirus infection in steroid-refractory Crohn's diseaseXavier Roblin, Sylvie Pillet, Philippe Berthelot, et al.
Journal of Crohn'S & Colitis|November 7, 2023
Higher Serum Infliximab Concentrations Following Subcutaneous Dosing are Associated with Deep Remission in Patients with Inflammatory Bowel DiseaseXavier Roblin, Stéphane Nancey, Konstantinos Papamichael, et al.
World Journal of Clinical Oncology|March 2, 2017
Difficult endoscopic diagnosis of a pancreatic plasmacytoma: Case report and review of literatureNicolas Williet, Radwan Kassir, Muriel Cuilleron, et al.
Pancreas|May 3, 2021
A Low Total Psoas Muscle Area Index Is a Strong Prognostic Factor in Metastatic Pancreatic CancerNicolas Williet, Marion Fovet, Khawla Maoui, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 26, 2019
Trough Levels of Infliximab at Week 6 Are Predictive of Remission at Week 14 in Pediatric Crohn's DiseaseOlivier Courbette, Camille Aupiais, Jérôme Viala, et al.
Inflammatory Bowel Diseases|May 17, 2014
Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysisStephane Paul, Amelie Carla Moreau, Emilie Del Tedesco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 17, 2017
Azathioprine for refractory ulcerative proctitis: A retrospective multicenter studyAnne-Laure Mallet, Guillaume Bouguen, Guillaume Conroy, et al.
Pageof 26